Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H23NO6 |
Molecular Weight | 385.4104 |
Optical Activity | UNSPECIFIED |
Additional Stereochemistry | Yes |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | M-helix |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C(OC)=C1OC)C3=CC=C(O)C(=O)C=C3[C@H](CC2)NC(C)=O
InChI
InChIKey=PRGILOMAMBLWNG-HNNXBMFYSA-N
InChI=1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)/t15-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9041381
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9041381
Colchiceine, a metabolite of colchicine, commonly used to treat gout, was studied as an effective compound in the model of liver damage.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9041381
in rats: CCl4 for 8 weeks followed by colchiceine (60 microg kg(-1)) + CCl4 for 5 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12020594
It was determined the cytotoxicity of colchiceine (EIN) in comparison with that of colchicine (COL); to evaluate the effect of EIN on cytochrome P450 (CYP) expression and activity. Primary human hepatocytes were the model of choice for cytotoxicity and CYP expression experiments. EIN was less toxic than COL based on both parameters within the concentration range 1-100 microM. 10 microM concentration of EIN did not induce the expression of CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 isoforms, which were evaluated at the levels of mRNAs, proteins and specific activities in culture. EIN in concentrations up to 200 microM had no effect on marker activities of CYP1A2, 2C9, 2E1 and 3A4 in human liver microsomes. It was concluded that EIN in concentrations up to 10 microM is not cytotoxic in primary human hepatocytes as revealed by albumin secretion and LDH leakage.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
HJ30158L57
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
207-512-5
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
477-27-0
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
234105
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
33411
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
DB15534
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
123396
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
HJ30158L57
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
DTXSID60878565
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
2174385
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | |||
|
m3724
Created by
admin on Sat Dec 16 08:51:53 GMT 2023 , Edited by admin on Sat Dec 16 08:51:53 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD